These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15947551)

  • 21. Natural coagulation inhibitory proteins and activated protein C resistance in Turkish patients with inflammatory bowel disease.
    Payzin B; Adakan FY; Yalçin HC; Cetinkaya GS; Berkmen S; Eraslan S; Unsal B
    Turk J Gastroenterol; 2006 Sep; 17(3):183-90. PubMed ID: 16941251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperhomocysteinemia and inflammatory bowel disease: prevalence and predictors in a cross-sectional study.
    Romagnuolo J; Fedorak RN; Dias VC; Bamforth F; Teltscher M
    Am J Gastroenterol; 2001 Jul; 96(7):2143-9. PubMed ID: 11467646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor V Leiden mutation is not increased in patients with inflammatory bowel disease.
    Zauber NP; Sabbath-Solitare M; Rajoria G; Mogan G
    J Clin Gastroenterol; 1998 Oct; 27(3):215-6. PubMed ID: 9802448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications.
    Mahmud N; Molloy A; McPartlin J; Corbally R; Whitehead AS; Scott JM; Weir DG
    Gut; 1999 Sep; 45(3):389-94. PubMed ID: 10446107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Analysis of Transcobalamin II Gene Polymorphisms and Serum Levels of Homocysteine, Folate and Vitamin B12 in Chinese Patients with Crohn's Disease.
    Zheng S; Wu C; Yang W; Xia X; Lin X; Jiang L; Ding R; Jiang Y
    Dig Dis; 2017; 35(5):463-471. PubMed ID: 28472811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperhomocysteinaemia, coagulation pathway activation and thrombophilia in patients with inflammatory bowel disease.
    Bjerregaard LT; Nederby NJ; Fredholm L; Brandslund I; Munkholm P; Hey H
    Scand J Gastroenterol; 2002 Jan; 37(1):62-7. PubMed ID: 11843038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum vitamin B12 and folate status in patients with inflammatory bowel diseases.
    Yakut M; Ustün Y; Kabaçam G; Soykan I
    Eur J Intern Med; 2010 Aug; 21(4):320-3. PubMed ID: 20603044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral challenge with a methionine load in patients with inflammatory bowel disease: a better test to identify hyperhomocysteinemia.
    Zepeda-Gómez S; Montano-Loza A; Zapata-Colindres JC; Vargas-Vorackova F; Majluf-Cruz A; Uscanga L
    Inflamm Bowel Dis; 2008 Mar; 14(3):383-8. PubMed ID: 17924554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis.
    Vecchi M; Sacchi E; Saibeni S; Meucci G; Tagliabue L; Duca F; De Franchis R
    Dig Dis Sci; 2000 Jul; 45(7):1465-9. PubMed ID: 10961731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease.
    Liebman HA; Kashani N; Sutherland D; McGehee W; Kam AL
    Gastroenterology; 1998 Oct; 115(4):830-4. PubMed ID: 9753484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural anticoagulant protein levels in Turkish patients with inflammatory bowel disease.
    Cakal B; Gokmen A; Yalinkilic M; Cakal E; Ayaz S; Nadir I; Ozin Y; Dagli U; Ulker A
    Blood Coagul Fibrinolysis; 2010 Mar; 21(2):118-21. PubMed ID: 20040858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and factor V Leiden.
    Jackson LM; O'Gorman PJ; O'Connell J; Cronin CC; Cotter KP; Shanahan F
    QJM; 1997 Mar; 90(3):183-8. PubMed ID: 9093595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications?
    Oldenburg B; Fijnheer R; van der Griend R; vanBerge-Henegouwen GP; Koningsberger JC
    Am J Gastroenterol; 2000 Oct; 95(10):2825-30. PubMed ID: 11051355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations in clotting factors and inflammatory bowel disease.
    Bernstein CN; Sargent M; Vos HL; Rosendaal FR
    Am J Gastroenterol; 2007 Feb; 102(2):338-43. PubMed ID: 17156138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance to activated protein C, factor V leiden and the prothrombin G20210A variant in patients with colorectal cancer.
    Paspatis GA; Sfyridaki A; Papanikolaou N; Triantafyllou K; Livadiotaki A; Kapsoritakis A; Lydataki N
    Pathophysiol Haemost Thromb; 2002; 32(1):2-7. PubMed ID: 12214157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease.
    Novacek G; Miehsler W; Kapiotis S; Katzenschlager R; Speiser W; Vogelsang H
    Am J Gastroenterol; 1999 Mar; 94(3):685-90. PubMed ID: 10086652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated protein C resistance in pediatric inflammatory bowel disease.
    Levine A; Lahav J; Zahavi I; Raz A; Dinari G
    J Pediatr Gastroenterol Nutr; 1998 Feb; 26(2):172-4. PubMed ID: 9481632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Association of transcobalamine II gene polymorphisms and serum homocysteine, vitamin B
    Zheng S; Wu H; Ye F; Xia X; Xia S; Lin X; Wu X; Jiang L; Ding R; Jiang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Oct; 34(5):731-736. PubMed ID: 28981944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency of prothrombotic risk factors in patients with deep venous thrombosis and controls: their implications for thrombophilia screening in Chilean subjects.
    Guzmán N; Salazar LA
    Genet Test Mol Biomarkers; 2010 Oct; 14(5):599-602. PubMed ID: 20707729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased genomic damage and vitamin B status in inflammatory bowel disease patients: A case-control, prospective, pilot study.
    Kim SY; Mun EC; Chung JW; Ha M; Ahn SM; Han MD; Han SH; Yun SC; Kim JH; Kim KO; Kim YJ; Kwon KA; Park DK
    Mutat Res Genet Toxicol Environ Mutagen; 2019 Jan; 837():42-47. PubMed ID: 30595208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.